Stocks
Genesco Financial Statements (GCO) |
||||||||||
| Genescosmart-lab.ru | % | 2024Q4 | 2025Q1 | 2025Q1 | 2025Q2 | 2025Q2 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 27.03.2024 | 30.04.2024 | 13.06.2024 | 31.07.2024 | 12.09.2024 | 12.09.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 739.0 | 457.6 | 457.6 | 525.2 | 525.2 | 1 966 | |||
| Operating Income, bln rub | 38.5 | -31.6 | -31.6 | -9.50 | -9.50 | -82.1 | ||||
| EBITDA, bln rub | ? | 52.5 | -31.6 | -18.4 | -9.56 | 3.59 | -56.0 | |||
| Net profit, bln rub | ? | 27.2 | -24.3 | -24.3 | -9.99 | -9.99 | -68.7 | |||
| OCF, bln rub | ? | 118.3 | -33.7 | 27.7 | -6.03 | |||||
| CAPEX, bln rub | ? | 10.6 | 6.38 | 7.90 | 14.3 | |||||
| FCF, bln rub | ? | 107.8 | -40.1 | 19.8 | -20.3 | |||||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | ||||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| OPEX, bln rub | 303.5 | 247.8 | 247.8 | 255.1 | 255.1 | 1 006 | ||||
| Cost of production, bln rub | 396.9 | 241.3 | 241.3 | 279.5 | 279.5 | 1 042 | ||||
| R&D, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Interest expenses, bln rub | 1.54 | 0.890 | 0.890 | 1.35 | 1.35 | 4.47 | ||||
| Assets, bln rub | 1 330 | 1 307 | 1 307 | 1 384 | 1 384 | 1 384 | ||||
| Net Assets, bln rub | ? | 571.2 | 548.5 | 548.5 | 532.6 | 532.6 | 532.6 | |||
| Debt, bln rub | 526.2 | 530.6 | 530.6 | 530.1 | 530.1 | 530.1 | ||||
| Cash, bln rub | 35.2 | 19.2 | 19.2 | 45.9 | 45.9 | 45.9 | ||||
| Net debt, bln rub | 491.1 | 511.3 | 511.3 | 484.3 | 484.3 | 484.3 | ||||
| Ordinary share price, rub | 28.8 | 25.3 | 24.4 | 30.8 | 27.6 | 27.0 | ||||
| Number of ordinary shares, mln | 10.9 | 10.9 | 10.9 | 10.9 | 10.9 | 10.9 | ||||
| Market cap, bln rub | 314 | 277 | 267 | 337 | 302 | 295 | ||||
| EV, bln rub | ? | 805 | 788 | 778 | 822 | 786 | 779 | |||
| Book value, bln rub | 534 | 548 | 512 | 533 | 496 | 496 | ||||
| EPS, rub | ? | 2.49 | -2.23 | -2.23 | -0.91 | -0.91 | -6.28 | |||
| FCF/share, rub | 9.88 | 0.00 | -3.67 | 0.00 | 1.81 | -1.86 | ||||
| BV/share, rub | 49.0 | 50.2 | 46.9 | 48.7 | 45.3 | 45.3 | ||||
| EBITDA margin, % | ? | 7.11% | -6.91% | -4.03% | -1.82% | 0.68% | -2.85% | |||
| Net margin, % | ? | 3.68% | -5.32% | -5.32% | -1.90% | -1.90% | -3.49% | |||
| FCF yield, % | ? | 30.2% | 39.0% | 25.3% | 20.1% | -6.73% | -6.88% | |||
| ROE, % | ? | 11.8% | 6.67% | 1.04% | -5.91% | -12.9% | -12.9% | |||
| ROA, % | ? | 5.07% | 2.80% | 0.43% | -2.28% | -4.96% | -4.96% | |||
| P/E | ? | 4.66 | 7.56 | 47.0 | -10.7 | -4.39 | -4.30 | |||
| P/FCF | 3.31 | 2.57 | 3.95 | 4.99 | -14.9 | -14.5 | ||||
| P/S | ? | 0.12 | 0.11 | 0.11 | 0.15 | 0.15 | 0.15 | |||
| P/BV | ? | 0.59 | 0.50 | 0.52 | 0.63 | 0.61 | 0.59 | |||
| EV/EBITDA | ? | 6.74 | 10.2 | 16.3 | -116.0 | -14.0 | -13.9 | |||
| Debt/EBITDA | 4.11 | 6.63 | 10.7 | -68.4 | -8.65 | -8.65 | ||||
| R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0 | ||||||
| CAPEX/Revenue, % | 1.43% | 0.00% | 1.39% | 0.00% | 1.50% | 0.73% | ||||
| Genesco shareholders | ||||||||||
